Search results
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June
FOX21 Colorado Springs· 6 days agoIn an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar ...
Why Cigna (CI) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 2 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Drug discount program is exploiting poor patients while corporate giants profit
Minnesota Reformer via Yahoo News· 5 days agoMinnesotans, with their long-valued sense of fairness and decency, would never suggest that Fortune...
Heavy rain causes Temple sewage overflows, Bartlett flooding
Temple Daily Telegram· 2 days agoFlooding from heavy weekend rainfall caused sewage overflows of more than 100,000 gallons in Temple...
Ginkgo Bioworks nominates two new board members By Investing.com
Investing.com· 2 days agoGinkgo Bioworks (NYSE: DNA), a company engaged in cell programming and biosecurity, has announced...
Walgreens launches specialty pharmacy unit to compete in new PBM era
AOL· 6 days agoWalgreens (WBA) is standing up a new specialty pharmacy segment to compete in an increasingly crowded pharmacy benefits manager (PBM) and specialty pharmacy space. The company announced Thursday ...
Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors
Fort Wayne Journal Gazette· 2 days agoToday, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the nomination of Myrtle Potter and Ross Fubini for election as independent ...
Why Cigna (CI) is a Top Value Stock for the Long-Term
Zacks· 3 days agoTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates ...